Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12-17  years

CONCLUSIONS: The incidences of myopericarditis after mRNA COVID-19 vaccination among adolescents aged 12-17 years were very rare; they were not higher than other important reference incidences. These findings provide an important context for health policy makers and parents with vaccination hesitancy to weight the risks and benefits of mRNA COVID-19 vaccination among adolescents aged 12-17 years.PMID:37246067 | PMC:PMC10201323 | DOI:10.1016/j.vaccine.2023.05.049
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research